Main Session
Oct
01
QP 19 - GI 4: Quick Pitch: Enhancing Efficacy for Esophageal cancer and Radiation Reponders for Rectal Cancer
1109 - Radiotherapy followed by Systemic Therapy and Tislelizumab in MSS Rectal Cancer with Unresectable Metastases: Results of the MIRACLE-2 Study
Presenter(s)
Zhen Zhang, MD, PhD - Fudan University Shanghai Cancer Center, shanghai, shanghai